Ulrik B. Nielsen, Director at MERRIMACK PHARMACEUTICALS INC (MACK), sold 20,000 shares at $10.71 ($214K) on 2015-07-20, disclosed to the SEC on 2015-07-22.
Scheduled sale ($214k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MACK | SELL | 2017-09-13 | $310K | — | Filing → |
| MACK | SELL | 2015-06-19 | $481K | — | Filing → |
| MACK | SELL | 2015-05-19 | $522K | — | Filing → |